Skip to main content

Table 1 DLEU2 expression associated with the clinicopathological parameters in GC

From: lncRNA DLEU2 promotes gastric cancer progression through ETS2 via targeting miR-30a-5p

Clinicopathological parameters

n

DLEU2 expression

P

Gender

 Male

55

1.437 ± 0.0617

0.5541

 Female

20

1.500 ± 0.0764

Age (years)

 < 60

33

1.507 ± 0.0731

0.8911

 ≥ 60

42

1.493 ± 0.0549

Tumor diameter (cm)

 < 5

31

1.473 ± 0.0727

0.1748

 ≥ 5

44

1.623 ± 0.0549

Pathological grading

 I–II

23

1.406 ± 0.0632

0.0087*

 III–IV

52

2.067 ± 0.1004

TNM staging

 T1–T2

15

1.997 ± 0.1695

0.0382*

 T3–T4

60

1.417 ± 0.0869

  1. *P < 0.05